Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro

AbstractPurpose. The purpose of this study was to demonstrate and characterize phagocytosis of poly(D,L-lactic-co-glycolic acid) (PLGA) nanospheres by human dendritic cells (DCs). Methods. Parallel cultures of DCs and macrophages (Mφ) were established from peripheral blood leukocytes using media supplemented with granulocyte-macrophage colony stimulator factor and interleukin-4 (for DC) or granulocyte-macrophage colony stimulator factor alone (for Mφ). PLGA nanospheres containing tetramethylrhodamine-labeled dextran with or without an adjuvant, monophosphoryl lipid A, were prepared using a water/oil/water solvent evaporation technique. Cells were incubated with the nanospheres for 24 h. Confocal laser scanning microscopy was used to determine the intracellular location of the nanospheres and flow cytometry to measure the fraction of phagocytic cells in the culture and the amount of uptake per cell. After phagocytosis, cells were stained for MHC class II molecules, CD14, CD80, and CD86 to identify the phagocytic population. Results. DCs phagocytosed PLGA nanospheres as efficiently as Mφ. Cell-surface marker expression conclusively established that the phagocytic cells were DC. Conclusions. DCs can take up PLGA nanospheres. Because DCs are the key professional antigen-presenting cells capable of stimulating naive T cells, our data suggest that PLGA nanospheres can be used as an efficient delivery system for vaccines designed to activate T cell-mediated immune responses.

[1]  J. Timmerman,et al.  Dendritic cell vaccines for cancer immunotherapy. , 1999, Annual review of medicine.

[2]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[3]  G. Kwon,et al.  Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses. , 1998, Journal of pharmaceutical sciences.

[4]  X M Li,et al.  Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. , 1996, Vaccine.

[5]  Marianne Ekman,et al.  Differentiation of human dendritic cells from monocytes in vitro , 1997, European journal of immunology.

[6]  G. Moore,et al.  Synthetic microspheres transferred to the rat oviduct on day 1 of pregnancy mimic the transport of native ova. , 1988, Journal of reproduction and fertility.

[7]  R. Steinman,et al.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo , 1993, The Journal of experimental medicine.

[8]  R. E. Sousa,et al.  PHAGOCYTOSIS OF ANTIGENS BY LANGERHANS CELLS , 1993 .

[9]  C. Partidos,et al.  Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles. , 1996, Journal of immunological methods.

[10]  Michael D. Roth,et al.  Human CD14+ leukocytes acquire the phenotype and function of antigen‐presenting dendritic cells when cultured in GM‐CSF and IL‐4 , 1996, Journal of leukocyte biology.

[11]  G. Kwon,et al.  Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. , 1998, Journal of pharmaceutical sciences.

[12]  R. Steinman,et al.  Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ. , 1993, Journal of cell science.

[13]  A. T. Davis,et al.  Cytochalasin B III. Inhibition of Human Polymorphonuclear Leukocyte Phagocytosis 1 , 1971 .

[14]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[15]  T Yashiki,et al.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.

[16]  E. Engleman,et al.  Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. , 1995, Immunology.

[17]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[18]  A. T. Davis,et al.  Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis. , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  J. Peters,et al.  Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. , 1995, Advances in experimental medicine and biology.

[20]  G. Kwon,et al.  Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[21]  G. Kwon,et al.  Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres , 1998, Cancer Immunology, Immunotherapy.

[22]  E. Engleman,et al.  Dendritic cells in cancer immunotherapy. , 2000, Annual review of immunology.

[23]  A. Enk,et al.  Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells , 1996, European journal of immunology.

[24]  C. Partidos,et al.  Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes. , 1996, Molecular immunology.

[25]  G. Trinchieri,et al.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.

[26]  H. Joller,et al.  Human dendritic cells phagocytose and process Borrelia burgdorferi. , 1996, Journal of immunology.

[27]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[28]  M. Croft,et al.  Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements , 1992, The Journal of experimental medicine.

[29]  L. Davis,et al.  Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. , 1993, Journal of immunology.

[30]  L. Adorini,et al.  Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. , 1995, Journal of immunology.